Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.29 CAD
Change Today +0.035 / 13.73%
Volume 5.0K
IMM On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 9:30 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

immunotec inc (IMM) Snapshot

Open
C$0.29
Previous Close
C$0.26
Day High
C$0.29
Day Low
C$0.29
52 Week High
09/3/14 - C$0.39
52 Week Low
07/20/15 - C$0.22
Market Cap
20.1M
Average Volume 10 Days
7.9K
EPS TTM
C$-0.05
Shares Outstanding
69.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUNOTEC INC (IMM)

Related News

No related news articles were found.

immunotec inc (IMM) Related Businessweek News

No Related Businessweek News Found

immunotec inc (IMM) Details

Immunotec Inc. develops, manufactures, markets, and sells natural health products and dietary supplements in Canada, the United States, Mexico, and internationally. The company’s flagship product is Immunocal, a natural source of glutathione precursor cysteine for the maintenance of immune system. It also offers Immunocal Platinum, a natural source of GSH cysteine precursor for the maintenance of immune system, as well as to maintain muscle function and bone health; Pure Milk Calcium, a calcium supplement; Omega-3 + CoQ10 with Turmeric to support health and brain functions, as well as to maintain and support cardiovascular health; vitamin and mineral supplements with resveratrol and chlorella; and probiotics with cranberry to modify gut flora. In addition, the company provides Magistral that supports prostate health; PNT 200, which reduces symptoms of mild mental and physical stress; Thermal Action tablets to manage weight; and K-21 for energy production, growth, and nourishment functions. Further, it offers Xtra Sharp to support and enhance general well-being, energy, and vitality; E-motion Energy to promote alertness and wakefulness, enhance cognitive performance, relieve fatigue, promote endurance, and enhance motor performance; concentrated cherry juices, skin perfecting creams, and toothpaste; and MiForm Transformation and Maintenance Kits, meal replacement shakes, and bars, as well as related accessories. The company also sells its products through online. Immunotec Inc. is headquartered in Vaudreuil-Dorion, Canada.

immunotec inc (IMM) Top Compensated Officers

Chief Executive Officer, Director and Chairma...
Total Annual Compensation: C$423.4K
Chief Financial Officer and Vice President
Total Annual Compensation: C$247.3K
Chief Operating Officer and Vice President
Total Annual Compensation: C$213.8K
Vice-President of Research & Development
Total Annual Compensation: C$206.5K
Vice President of Sales & Marketing
Total Annual Compensation: C$185.0K
Compensation as of Fiscal Year 2014.

immunotec inc (IMM) Key Developments

Immunotec Obtains $2,780,000 of New Financing

Immunotec Inc. announced that it has obtained additional financing from the Toronto Dominion Bank and a new credit facility from Export Development Canada. In addition to existing loans, the Corporation now benefits from a new operating loan from TD Bank in a maximum amount of $1,500,000, which is guaranteed by EDC, to be used to finance the growth and activities of the Corporation's Mexican subsidiaries. New reducing term facilities from TD Bank and EDC in the total amount of $1,280,000 will be used namely for the acquisition by the Corporation of fixed assets and the modernisation of Immunotec's manufacturing infrastructure in support of Immunotec's export activities.

Immunotec Inc. Reports Consolidated Earnings Results for the Second Quarter and Six Months April 30, 2015

Immunotec Inc. reported consolidated earnings results for the second quarter and six months April 30, 2015. For the quarter, the company reported revenue of CAD 20 million compared to CAD 19.1 million reported in the same period last year. Net profit was CAD 0.3 million against CAD 0.8 million reported last year. Adjusted EBITDA was CAD 1.39 million against CAD 1.4 million reported last year. For the six months, the company reported revenue of CAD 37.9 million compared to CAD 35.2 million reported in the same period last year. Net profit was CAD 1.2 million against CAD 1.5 million reported last year. Adjusted EBITDA was CAD 2.5 million against CAD 2.2 million reported last year.

Immunotec Inc. Announces Consolidated Earnings Results for the First Quarter Ended January 31, 2015

Immunotec Inc. announced consolidated earnings results for the first quarter ended January 31, 2015. For the quarter, revenues of CAD 17,918,000, operating income of CAD 965,000 and net profit of CAD 852,000 or CAD 0.01 per basic and diluted share against revenues of CAD 16,156,000, operating income of CAD 572,000 and net profit of CAD 759,000 or CAD 0.01 per basic and diluted share for the same period a year ago. Adjusted EBITDA was CAD 1,122,000 against CAD 763,000 for the same period a year ago. EBITDA was CAD 1,122,000 against CAD 763,000 for the same period a year ago. The growth in revenue was generated by increased sales in both Mexico and the United States, consistent with prior quarterly reporting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMM:CN C$0.29 CAD +0.035

IMM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMM.
View Industry Companies
 

Industry Analysis

IMM

Industry Average

Valuation IMM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOTEC INC, please visit www.immunotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.